Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

被引:16
|
作者
Campanella, N
Moraca, A
Pergolini, M
Daher, W
Fianchini, A
Sabbatini, A
Brunelli, A
Al-Refai, M
机构
[1] Umberto I Torrette Reg Hosp, Med Pathol Inst, Ancona, Italy
[2] Univ Ancona, Dept Thorac Surg, Ancona, Italy
关键词
paraneoplastic syndromes; lung; cancer; bronchogenic; prevalence; non-small cell lung carcinoma; early diagnosis;
D O I
10.1007/BF02785846
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the importance of paraneoplastic syndromes as an early sign of non-small cell lung cancer (NSCLC). A procedure for searching paraneoplastic syndromes, based on 40 years of reports in the literature, was established and the prevalence of paraneoplastic syndromes estimated in 68 patients with resectable NSCLC. Stages I and II were considered eligible for surgery straight away. Patients in Stage IIIA underwent surgery if partially or completely responsive to three courses of neo-adjuvant chemotherapy, Paraneoplastic syndromes were assessed and confirmed in nine patients (13%). Motor-sensory neuropathy, arthritis and arthralgias to the knees, periarthritis to the shoulder, hypertrophic osteopathy, clubbing, pruritus were observed, Only three patients with painful osteoarthropathies were diagnosed with NSCLC by tracing their paraneoplastic syndrome, whereas most of them (36/68) were diagnosed incidentally through a chest radiograph taken for tumour-unrelated symptoms. A careful research of paraneoplastic syndromes in high risk patients may guide the doctor to a resectable NSCLC diagnosis. Recent onset arthritis and arthralgias, which cannot be explained otherwise, should be considered to be early clues of lung cancer.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [31] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [32] Role of pneumonectomy in the management of resectable non-small cell lung
    Landreneau, Rodney J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S130 - S130
  • [33] SMALL CELL-CARCINOMA OF LUNG - STAGING, PARANEOPLASTIC SYNDROMES, TREATMENT, AND SURVIVAL
    EAGAN, RT
    MAURER, LH
    FORCIER, RJ
    TULLOH, M
    CANCER, 1974, 33 (02) : 527 - 532
  • [34] Peptide neurotoxins, small-cell lung carcinoma and neurological paraneoplastic syndromes
    Sher, E
    Giovannini, F
    Boot, J
    Lang, B
    BIOCHIMIE, 2000, 82 (9-10) : 927 - 936
  • [35] Serum tumor markers in resectable and non-resectable non-small cell lung cancer
    Nisman, B
    Heching, N
    Barak, V
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2000, 15 (03): : 195 - 207
  • [36] Surgical pathology of early stage non-small cell lung carcinoma
    Beasley, Mary Beth
    Dembitzer, Francine R.
    Flores, Raja M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (12) : 1 - 8
  • [37] Somatic mutation variant analysis in rural, resectable non-small cell lung carcinoma patients
    Mitchem, Jonathan B.
    Miller, Amanda
    Manjunath, Yariswamy
    Barbirou, Mouadh
    Raju, Murugesan
    Shen, Yuanyuan
    Li, Guangfu
    Avella, Diego M.
    Chaudhuri, Aadel A.
    Shyu, Chi-Ren
    Warren, Wesley C.
    Tonellato, Peter J.
    Kaifi, Jussuf T.
    CANCER GENETICS, 2022, 268 : 75 - 82
  • [38] Detection of novel genetic alterations in non-small cell lung carcinoma
    Garnis, C
    Buys, T
    Lockwood, W
    Vucic, E
    MacAulay, C
    Lam, S
    Lam, W
    LUNG CANCER, 2005, 49 : S125 - S125
  • [39] DETECTION OF SOLUBLE HLA ANTIGENS (SHLA) IN BLOOD FOR EARLY DETECTION OF NON-SMALL CELL LUNG CARCINOMA (NSCLC)
    Kanangat, Smriti
    Fhied, Cristina
    Pergande, Melissa
    Borgia, Jeffrey
    DeCresce, Robert
    Prod, Michele H.
    HUMAN IMMUNOLOGY, 2016, 77 : 65 - 65
  • [40] PPARα Activation Can Help Prevent and Treat Non-Small Cell Lung Cancer
    Skrypnyk, Nataliya
    Chen, Xiwu
    Hu, Wen
    Su, Yan
    Mont, Stacey
    Yang, Shilin
    Gangadhariah, Mahesha
    Wei, Shouzuo
    Falck, John R.
    Jat, Jawahar Lal
    Zent, Roy
    Capdevila, Jorge H.
    Pozzi, Ambra
    CANCER RESEARCH, 2014, 74 (02) : 621 - 631